.png){kind=icon}
COVID-19: Commercialization & Reimbursement
将市场访问和第IV阶段解决方案合并到您的Covid-19计划策略中。我们提供全面的真实安全，疗效和患者访问提供，以获得和PERI批准研究。
晚期和商业化活动是复杂的，需要明智的策略来最大限度地提高您的产品的临床和商业价值。我们可以帮助您通过准备推出和商业化Covid-19产品，帮助您实现独特的挑战，确保患者能够获得安全有效的治疗方法。
生成证据，传达价值和加快患者访问
一旦可行的Covid-19疫苗或治疗达到市场，必须通过向付款人和医生传达其价值来改善科学和治疗性进展至关重要，同时导航偿还案件挑战促进快速访问对患者和付款人。
企业连续性规划在患者支持方案中的重要性
It’s never too early to evaluate your current and future reimbursement call center strategy and be as prepared as possible for the unexpected events that interrupt patient access to your COVID-19 therapy.
监控Covid-19疫苗或治疗的持续安全性和疗效
将患者安全旅程从临床试验中规划到营销后，以确保患者的安全和监管合规性，同时提高质量和数据完整性，并获得对您的安全的有价值的见解pharmacovigilance operations.
Proactively Plan to Fulfill Your Post-Approval COVID-19 Commitments
作为您的伴侣，我们可以通过利用现实世界的证据（RWE）和创新的第四阶段研究来优化患者支持，遵守和产品访问，以证明您的Covid-19产品的价值，功效和安全到付款人，处方和监管机构，如以及为您提供世界领先的安全解决方案组合。
- Successfully collect RWE and extend the value of your compound
- Strengthen your market position and support uptake
- 填补登记要求与战略后期研究设计之间的差距
- 以有意义的方式和患者通过患者报告的结果（专业人士）与患者一起参与
On Demand Webinar: Vaccine Innovation in the Era of COVID-19: Safety at a Pandemic Speed
主持人：Jerome Premmereur，VP患者安全解决方案和裁决，Covance
概括：
During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID-19. Regardless of the great recent advancements in genomic and molecular biology, a viable vaccine approval is still likely to be over a year away. This webinar will discuss the challenges and safety issues surrounding a vaccine approval at “pandemic speed”.
播客：Covid-19锁定期间的药物不良事件报告
特色：Thomas Leigh博士
概括：
A podcast featuring Dr. Thomas Leigh, an Executive Medical Director and Head of the Medical Group at Covance Patient Safety Solutions & Adjudication -- The global COVID-19 pandemic has brought new urgency and challenges to reporting drug adverse events in clinical trials and the consumer market. It may well be the case in the months to come that we learn of adverse events which took place during the lockdown but which are only reported at a much later stage. The pandemic and its effects are significant, and it will be very important for all of us involved in the assessment of safety of medicines to look out for evidence of safety events which perhaps have not previously come to light.
Connect with our COVID-19 Response Team
联系我们
Covance by Labcorp is a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries.
Covance是Covance Inc.的注册商标和营销名称及其周围的子公司。